{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:47:33Z","timestamp":1791398853529,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jconrel.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T06:45:03Z","timestamp":1712385903000},"page":"444-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic cancer therapy"],"prefix":"10.1016","volume":"369","author":[{"given":"Xingwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2024.04.004_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41568-021-00418-1","article-title":"Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data","volume":"22","author":"Connor","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2024.04.004_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.jconrel.2024.04.004_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nnano.2012.45","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","volume":"7","author":"Chauhan","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.04.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12022","article-title":"Ferritin-based drug delivery system for tumor therapy","volume":"1","author":"Tu","year":"2023","journal-title":"BMEMat"},{"issue":"9","key":"10.1016\/j.jconrel.2024.04.004_bb0025","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of Cancer nanomedicines\u2014lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2024.04.004_bb0030","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"7","key":"10.1016\/j.jconrel.2024.04.004_bb0035","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41565-021-00897-1","article-title":"Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer","volume":"16","author":"Li","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.04.004_bb0040","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/mp100038h","article-title":"The effects of particle size and molecular targeting on the Intratumoral and subcellular distribution of polymeric nanoparticles","volume":"7","author":"Lee","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.04.004_bb0045","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2015.08.017","article-title":"Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors","volume":"219","author":"Miao","year":"2015","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.jconrel.2024.04.004_bb0050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."},{"issue":"12","key":"10.1016\/j.jconrel.2024.04.004_bb0055","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41565-019-0570-3","article-title":"Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies","volume":"14","author":"Sung","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"21","key":"10.1016\/j.jconrel.2024.04.004_bb0060","doi-asserted-by":"crossref","first-page":"8744","DOI":"10.1021\/acs.nanolett.2c03663","article-title":"Stromal homeostasis-restoring nanomedicine enhances pancreatic Cancer chemotherapy","volume":"22","author":"Yu","year":"2022","journal-title":"Nano Lett."},{"issue":"5","key":"10.1016\/j.jconrel.2024.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.biomac.7b00068","article-title":"Enhancing tumor penetration of nanomedicines","volume":"18","author":"Sun","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2024.04.004_bb0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jconrel.2023.11.044","article-title":"CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy","volume":"365","author":"M\u00f6ckel","year":"2024","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2024.04.004_bb0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41563-020-0672-1","article-title":"Active transcytosis and new opportunities for cancer nanomedicine","volume":"19","author":"Pandit","year":"2020","journal-title":"Nat. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2024.04.004_bb0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2024.04.004_bb0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","article-title":"Enzyme-activatable polymer\u2013drug conjugate augments tumour penetration and treatment efficacy","volume":"14","author":"Zhou","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.jconrel.2024.04.004_bb0090","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-023-00783-w","article-title":"Optimizing the safety of antibody\u2013drug conjugates for patients with solid tumours","volume":"20","author":"Tarantino","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5981","key":"10.1016\/j.jconrel.2024.04.004_bb0095","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs","volume":"328","author":"Sugahara","year":"2010","journal-title":"Science (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.jconrel.2024.04.004_bb0100","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1172\/JCI92284","article-title":"Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer","volume":"127","author":"Liu","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.jconrel.2024.04.004_bb0105","doi-asserted-by":"crossref","first-page":"2300594","DOI":"10.1002\/adhm.202300594","article-title":"The efficacy of nanoparticle delivery to hypoxic solid tumors by ciRGD co-administration depends on neuropilin-1 and neutrophil levels","volume":"12","author":"Izci","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"10","key":"10.1016\/j.jconrel.2024.04.004_bb0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2468-1253(22)00167-4","article-title":"Dual \u03b1V-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study","volume":"7","author":"Dean","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.04.004_bb0115","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1038\/s41467-021-25856-1","article-title":"Modular ketal-linked prodrugs and biomaterials enabled by organocatalytic transisopropenylation of alcohols","volume":"12","author":"Yu","year":"2021","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.jconrel.2024.04.004_bb0120","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1096\/fj.00-0250com","article-title":"Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression","volume":"14","author":"Miao","year":"2000","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.jconrel.2024.04.004_bb0125","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/polym12091906","article-title":"iRGD peptide as a tumor-penetrating enhancer for tumor-targeted drug delivery","volume":"12","author":"Kang","year":"2020","journal-title":"Polymers"},{"issue":"11","key":"10.1016\/j.jconrel.2024.04.004_bb0130","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.04.004_bb0135","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2021.05.055","article-title":"Tumor-specific delivery of 5-fluorouracil\u2013incorporated epidermal growth factor receptor\u2013targeted aptamers as an efficient treatment in pancreatic ductal adenocarcinoma models","volume":"161","author":"Mahajan","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jconrel.2024.04.004_bb0140","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/1078-0432.CCR-08-0515","article-title":"Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors","volume":"15","author":"Batist","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.jconrel.2024.04.004_bb0145","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1021\/acs.nanolett.0c01973","article-title":"Dually enzyme- and acid-triggered self-Immolative ketal glycoside nanoparticles for effective Cancer prodrug monotherapy","volume":"20","author":"Yu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.04.004_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2023.05.045","article-title":"Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugates","volume":"359","author":"Guo","year":"2023","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2024.04.004_bb0155","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/acs.biomac.9b01493","article-title":"Acid-triggered release of native gemcitabine conjugated in Polyketal nanoparticles for enhanced anticancer therapy","volume":"21","author":"Zhong","year":"2020","journal-title":"Biomacromolecules"},{"issue":"9","key":"10.1016\/j.jconrel.2024.04.004_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108135","article-title":"PDLLA length on anti-breast cancer efficacy of acid-responsive self-assembling mPEG-PDLLA\u2013docetaxel conjugates","volume":"34","author":"Liu","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"40","key":"10.1016\/j.jconrel.2024.04.004_bb0165","doi-asserted-by":"crossref","first-page":"1703135","DOI":"10.1002\/adma.201703135","article-title":"Self-assembly of an amphiphilic janus camptothecin\u2013floxuridine conjugate into liposome-like nanocapsules for more efficacious combination chemotherapy in cancer","volume":"29","author":"Liang","year":"2017","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2024.04.004_bb0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2011.05.037","article-title":"5-Ethynyl-2\u2032-deoxycytidine as a new agent for DNA labeling: detection of proliferating cells","volume":"417","author":"Qu","year":"2011","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.jconrel.2024.04.004_bb0175","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/cbdd.13323","article-title":"Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice","volume":"92","author":"Hu","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"issue":"5","key":"10.1016\/j.jconrel.2024.04.004_bb0180","doi-asserted-by":"crossref","first-page":"e2815","DOI":"10.1038\/cddis.2017.220","article-title":"Furanodienone induces G0\/G1 arrest and causes apoptosis via the ROS\/MAPKs-mediated caspase-dependent pathway in human colorectal cancer cells: a study in vitro and in vivo","volume":"8","author":"Jiang","year":"2017","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2024.04.004_bb0185","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/09731296231184539","article-title":"Corilagin induces ROS-mediated apoptosis and triggers cell-cycle arrest at G0\/G1 stage in osteosarcoma cells","volume":"19","author":"Liu","year":"2023","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.jconrel.2024.04.004_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.03.008","article-title":"Tumor penetrating peptides for improved drug delivery","volume":"110-111","author":"Ruoslahti","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.jconrel.2024.04.004_bb0195","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S2468-1253(22)00197-2","article-title":"CEND-1: a game changer for pancreatic cancer chemotherapy?","volume":"7","author":"Springfeld","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"28","key":"10.1016\/j.jconrel.2024.04.004_bb0200","doi-asserted-by":"crossref","first-page":"2214937","DOI":"10.1002\/adfm.202214937","article-title":"Transcytosis mediated deep tumor penetration for enhanced chemotherapy and immune activation of pancreatic cancer","volume":"33","author":"Chen","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2024.04.004_bb0205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1535-7163.MCT-14-0366","article-title":"Tumor-penetrating iRGD peptide inhibits metastasis","volume":"14","author":"Sugahara","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2024.04.004_bb0210","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.3390\/ijms24065700","article-title":"Assessment of the pharmacokinetics, disposition, and duration of action of the tumour-targeting peptide CEND-1","volume":"24","author":"J\u00e4rvel\u00e4inen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2024.04.004_bb0215","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/gt.2014.52","article-title":"iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy","volume":"21","author":"Puig-Saus","year":"2014","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2024.04.004_bb0220","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41467-021-21858-1","article-title":"Tumor-penetrating therapy for \u03b25 integrin-rich pancreas cancer","volume":"12","author":"Hurtado de Mendoza","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T01:56:57Z","timestamp":1728525417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924002256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":44,"alternative-id":["S0168365924002256"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.004","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}